Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Spark raises $112.5M in follow-on

    Gene therapy play Spark Therapeutics Inc. (NASDAQ:ONCE) raised $112.5 million through the sale of 2.5 million shares at $45 in a follow-on underwritten by JPMorgan, Cowen, RBC Capital, Stifel and SunTrust. Selling …

    Published on 6/15/2016
  • FINANCIAL NEWS: Gilde closes EUR 250 million fund

    Gilde Healthcare closed its Gilde Healthcare IV fund at EUR 250 million ($281.8 million). The oversubscribed later-stage growth capital fund will invest in private medtech, digital health and therapeutics companies in …

    Published on 6/14/2016
  • FINANCIAL NEWS: Minerva raises $50M in follow-on

    Minerva Neurosciences Inc. (NASDAQ:NERV) raised $50 million through the sale of 5.3 million shares at $9.50 in a follow-on underwritten by Jefferies and JMP Securities. Minerva proposed the offering late Monday, when …

    Published on 6/14/2016
  • FINANCIAL NEWS: Alpine raises $48M series A round

    Alpine Immune Sciences Inc. (Seattle, Wash.) raised $48 million in a series A round led by OrbiMed Advisors. Frazier Healthcare Partners and seed investor Alpine BioVentures also participated. Alpine is developing …

    Published on 6/13/2016
  • FINANCIAL NEWS: NMD raises $3M seed round

    NMD Pharma (Aarhus, Denmark) raised $3 million in a seed round from Lundbeckfonden Emerge, Novo Seeds and Capnova. NMD is developing small molecules that increase neuromuscular transmission to treat Orphan motor neuron …

    Published on 6/13/2016
  • FINANCIAL NEWS: Vivo Capital closes new early stage fund

    Vivo Capital closed its new Vivo Panda fund with more than $100 million to invest primarily in early stage healthcare companies, including biotech, medtech and diagnostics. Vivo said the new fund will complement its $…

    Published on 6/13/2016
  • FINANCIAL NEWS: KPCB's Perkins passes away

    Kleiner Perkins Caufield & Byers co-founder Thomas Perkins passed away Tuesday at age 84, according to his assistant Kathy Daly.Among the firm's many life sciences investments was Genentech Inc., where Perkins was …

    Published on 6/10/2016
  • FINANCIAL NEWS: Freenome raises $5.5M seed round

    Liquid biopsy company Freenome Inc. (Palo Alto, Calif.) raised $5.5 million in a seed round led by Andreessen Horowitz. Founders Fund, Data Collective, Third Kind Venture Capital and other investors also participated. …

    Published on 6/9/2016
  • FINANCIAL NEWS: Sarepta raises $37.5M in follow-on

    Sarepta Therapeutics Inc. (NASDAQ:SRPT) raised $37.5 million in a follow-on underwritten by Credit Suisse and Robert W. Baird. Sarepta told BioCentury the company sold 2.1 million shares at $18.70, the high end of the …

    Published on 6/9/2016
  • FINANCIAL NEWS: Dermira raises $126M in follow-on

    Dermira Inc. (NASDAQ:DERM) raised $126 million through the sale of 4.5 million shares at $28 in a follow-on underwritten by Leerink, Cowen, Guggenheim and Needham. Dermira proposed the offering after market close on …

    Published on 6/8/2016
  • FINANCIAL NEWS: Flexion dips after $77M follow-on

    Flexion Therapeutics Inc. (NASDAQ:FLXN) raised $77 milion through the sale of 5.5 million shares at $14 in a follow-on underwritten by Wells Fargo, RBC Capital Markets, BMO Capital Markets, Janney Montgomery Scott and …

    Published on 6/8/2016
  • FINANCIAL NEWS: Genomics play Omicia raises $23M

    Omicia Inc. (Oakland, Calif.) raised $23 million in a series B round. New investors in the round included UPMC Enterprises, Roche Venture Fund, LDV Partners, Ping An Ventures, and an undisclosed investor in the genomics…

    Published on 6/8/2016
  • FINANCIAL NEWS: Merck KGaA bulks up venture activities

    Merck KGaA (Xetra:MRK) said its corporate venture arm will invest in new areas beyond biopharma. The fund, now named Merck Ventures BV, will invest in healthcare, life sciences and performance materials companies, as …

    Published on 6/8/2016
  • FINANCIAL NEWS: Sorrento closes $150M private placements

    Oncology company Sorrento Therapeutics Inc. (NASDAQ:SRNE) closed a set of private placements in which it raised $150 million.A group including Ally Bridge Group, Beijing Shijilongxin Investment Co. Ltd. and Frejoy …

    Published on 6/8/2016
  • FINANCIAL NEWS: Longitude closes third fund at $525M

    Longitude Capital closed its Longitude Venture Partners III at its hard cap of $525 million, above the original target of $450 million. The firm said it will continue to invest in clinical- and commercial-stage biotech …

    Published on 6/7/2016
  • FINANCIAL NEWS: VBL raises $24M after boost from ovarian cancer data

    VBL Therapeutics Ltd. (NASDAQ:VBLT) raised $24 million on Tuesday through the sale of 4.4 million shares at $5.50 in a registered direct offering with institutional investors. The Rodman & Renshaw unit of H.C. …

    Published on 6/7/2016
  • FINANCIAL NEWS: Applied StemCell raises $19M in series D

    Applied StemCell Inc. (Milpitas, Calif.) raised $19 million in a series D round led by HerMed Capital. Ping An Ventures, Vi Ventures and BioSciKin, a subsidiary of Simcere Pharmaceutical Group (Nanjing, China), also …

    Published on 6/6/2016
  • FINANCIAL NEWS: Microbiome play Vedanta raises $50M

    Vedanta Biosciences Inc. (Boston, Mass.) raised $50 million in a series B round. Existing investor PureTech Health plc (LSE:PRTC) supplied about $30 million, giving it a 75.4% post-money stake. Invesco Asset Management …

    Published on 6/6/2016
  • FINANCIAL NEWS: argenx raises EUR 30 million

    argenx N.V. (Euronext:ARGX) raised EUR 30 million ($33.4 million) through the sale of 2.7 million shares at EUR 11.10 in a private placement, mainly with U.S. investors. The price was a 3% discount to argenx's close of …

    Published on 6/3/2016
  • FINANCIAL NEWS: Lion raises $100M, names new CEO

    Cancer immunotherapy company Lion Biotechnologies Inc. (NASDAQ:LBIO) raised $100 million in a private placement led by Quogue Capital, OrbiMed, Frazier Healthcare Partners and Broadfin Capital. The investor group is …

    Published on 6/3/2016
  • FINANCIAL NEWS: Ablynx raises EUR 74.2 million

    Antibody company Ablynx N.V. (Euronext:ABLX) raised EUR 74.2 million ($82.5 million) through a private placement of 5.5 million shares at EUR 13.40. The price is a 6% discount to Ablynx' close of EUR 14.30 on Wednesday,…

    Published on 6/2/2016
  • FINANCIAL NEWS: Cell Design raises $34.4M, partners with Kite

    Cell Design Labs Inc. (San Francisco, Calif.) raised $34.4 million in venture funding led by Kleiner Perkins Caufield & Byers, with participation from Kite Pharma Inc. (NASDAQ:KITE), Osage Ventures, Mission Bay Ventures…

    Published on 6/2/2016
  • FINANCIAL NEWS: LSP closes fifth fund at $280 million

    LSP closed its fifth fund, LSP 5, at a hard cap of $280 million, well above its initial target of $170 million. The firm plans to invest LSP 5 with the same strategy as previous funds, targeting investments in about 20 …

    Published on 6/2/2016
  • FINANCIAL NEWS: NantHealth, Clearside rise after pricing IPOs

    NantHealth Inc. (NASDAQ:NH) and Clearside Biomedical Inc. (NASDAQ:CLSD) each posted gains in their first day of trading Thursday after pricing IPOs.NantHealth gained $4.59 (33%) to $18.59 after it raised $91 million …

    Published on 6/2/2016
  • FINANCIAL NEWS: AC Immune planning NASDAQ listing

    Neurology company AC Immune S.A. (Lausanne, Switzerland) filed to raise up to $50 million in an IPO on NASDAQ underwritten by Credit Suisse, Jefferies and Leerink Partners. AC Immune's lead program is crenezumab (RG7412…

    Published on 6/1/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993